These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Optimization of cerebral organoids: a more qualified model for Alzheimer's disease research. Bi FC; Yang XH; Cheng XY; Deng WB; Guo XL; Yang H; Wang Y; Li J; Yao Y Transl Neurodegener; 2021 Aug; 10(1):27. PubMed ID: 34372927 [TBL] [Abstract][Full Text] [Related]
3. Enhanced Neuronal Activity and Asynchronous Calcium Transients Revealed in a 3D Organoid Model of Alzheimer's Disease. Yin J; VanDongen AM ACS Biomater Sci Eng; 2021 Jan; 7(1):254-264. PubMed ID: 33347288 [TBL] [Abstract][Full Text] [Related]
4. Modeling Sporadic Alzheimer's Disease in Human Brain Organoids under Serum Exposure. Chen X; Sun G; Tian E; Zhang M; Davtyan H; Beach TG; Reiman EM; Blurton-Jones M; Holtzman DM; Shi Y Adv Sci (Weinh); 2021 Sep; 8(18):e2101462. PubMed ID: 34337898 [TBL] [Abstract][Full Text] [Related]
5. Mouse induced pluripotent stem cells-derived Alzheimer's disease cerebral organoid culture and neural differentiation disorders. Fan W; Sun Y; Shi Z; Wang H; Deng J Neurosci Lett; 2019 Oct; 711():134433. PubMed ID: 31421155 [TBL] [Abstract][Full Text] [Related]
6. Human Pluripotent Stem Cell-Derived Neural Cells as a Relevant Platform for Drug Screening in Alzheimer's Disease. Garcia-Leon JA; Caceres-Palomo L; Sanchez-Mejias E; Mejias-Ortega M; Nuñez-Diaz C; Fernandez-Valenzuela JJ; Sanchez-Varo R; Davila JC; Vitorica J; Gutierrez A Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962164 [TBL] [Abstract][Full Text] [Related]
7. Human iPSC-Derived Neural Models for Studying Alzheimer's Disease: from Neural Stem Cells to Cerebral Organoids. Barak M; Fedorova V; Pospisilova V; Raska J; Vochyanova S; Sedmik J; Hribkova H; Klimova H; Vanova T; Bohaciakova D Stem Cell Rev Rep; 2022 Feb; 18(2):792-820. PubMed ID: 35107767 [TBL] [Abstract][Full Text] [Related]
8. Stem cell models of Alzheimer's disease: progress and challenges. Arber C; Lovejoy C; Wray S Alzheimers Res Ther; 2017 Jun; 9(1):42. PubMed ID: 28610595 [TBL] [Abstract][Full Text] [Related]
9. Human-Induced Pluripotent Stem Cell (hiPSC)-Derived Neurons and Glia for the Elucidation of Pathogenic Mechanisms in Alzheimer's Disease. Young JE; Goldstein LSB Methods Mol Biol; 2023; 2561():105-133. PubMed ID: 36399267 [TBL] [Abstract][Full Text] [Related]
10. Cerebral organoids derived from patients with Alzheimer's disease with PSEN1/2 mutations have defective tissue patterning and altered development. Vanova T; Sedmik J; Raska J; Amruz Cerna K; Taus P; Pospisilova V; Nezvedova M; Fedorova V; Kadakova S; Klimova H; Capandova M; Orviska P; Fojtik P; Bartova S; Plevova K; Spacil Z; Hribkova H; Bohaciakova D Cell Rep; 2023 Nov; 42(11):113310. PubMed ID: 37864790 [TBL] [Abstract][Full Text] [Related]
11. Three-dimensional modeling of human neurodegeneration: brain organoids coming of age. Grenier K; Kao J; Diamandis P Mol Psychiatry; 2020 Feb; 25(2):254-274. PubMed ID: 31444473 [TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease and synapse Loss: What can we learn from induced pluripotent stem Cells? Rodriguez-Jimenez FJ; Ureña-Peralta J; Jendelova P; Erceg S J Adv Res; 2023 Dec; 54():105-118. PubMed ID: 36646419 [TBL] [Abstract][Full Text] [Related]
13. Modeling neurodegenerative diseases with cerebral organoids and other three-dimensional culture systems: focus on Alzheimer's disease. Venkataraman L; Fair SR; McElroy CA; Hester ME; Fu H Stem Cell Rev Rep; 2022 Feb; 18(2):696-717. PubMed ID: 33180261 [TBL] [Abstract][Full Text] [Related]
14. Human Pluripotent Stem Cells as In Vitro Models of Neurodegenerative Diseases. Machairaki V Adv Exp Med Biol; 2020; 1195():93-94. PubMed ID: 32468463 [TBL] [Abstract][Full Text] [Related]
15. Modelling Alzheimer's disease using human brain organoids: current progress and challenges. Yanakiev M; Soper O; Berg DA; Kang E Expert Rev Mol Med; 2022 Dec; 25():e3. PubMed ID: 36517884 [TBL] [Abstract][Full Text] [Related]
16. Current progress of cerebral organoids for modeling Alzheimer's disease origins and mechanisms. Sreenivasamurthy S; Laul M; Zhao N; Kim T; Zhu D Bioeng Transl Med; 2023 Mar; 8(2):e10378. PubMed ID: 36925717 [TBL] [Abstract][Full Text] [Related]
17. Modeling and Targeting Alzheimer's Disease With Organoids. Papaspyropoulos A; Tsolaki M; Foroglou N; Pantazaki AA Front Pharmacol; 2020; 11():396. PubMed ID: 32300301 [TBL] [Abstract][Full Text] [Related]
18. Modeling amyloid beta and tau pathology in human cerebral organoids. Gonzalez C; Armijo E; Bravo-Alegria J; Becerra-Calixto A; Mays CE; Soto C Mol Psychiatry; 2018 Dec; 23(12):2363-2374. PubMed ID: 30171212 [TBL] [Abstract][Full Text] [Related]
19. Modeling Alzheimer's Disease Using Human Brain Organoids. Karmirian K; Holubiec M; Goto-Silva L; Fernandez Bessone I; Vitória G; Mello B; Alloatti M; Vanderborght B; Falzone TL; Rehen S Methods Mol Biol; 2023; 2561():135-158. PubMed ID: 36399268 [TBL] [Abstract][Full Text] [Related]
20. A logical network-based drug-screening platform for Alzheimer's disease representing pathological features of human brain organoids. Park JC; Jang SY; Lee D; Lee J; Kang U; Chang H; Kim HJ; Han SH; Seo J; Choi M; Lee DY; Byun MS; Yi D; Cho KH; Mook-Jung I Nat Commun; 2021 Jan; 12(1):280. PubMed ID: 33436582 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]